• Meta-analysis
  • Pain Science & Central Sensitization
  • Systematic Reviews & Meta-analyses
  • Treatment: Exercise & Movement
Clinical RelevanceDOI 5 min read
Jump to:

Patient-friendly summary

If you read nothing else

Teaching people with long-term low back pain how pain works in the nervous system — usually alongside exercise — appears to lower their pain, disability, and fear of movement for at least a few months.

Bottom line

Across 15 randomized trials, pain neuroscience education added to exercise or physiotherapy was associated with reduced pain, disability, kinesiophobia, and catastrophizing in chronic low back pain, but small, varied trials and possible publication bias mean the evidence is promising rather than conclusive.

Moderate evidence

Published

2025
1 years ago
Current

Evidence hierarchy

Meta-analysis ◀ this study
Systematic Review
RCT
Cohort
Case-Control
Case Report
Expert Opinion

Study participants

810 patients across 15 RCTs (407 PNE, 403 control)Mean 43.7 ± 5.2 yearsApproximately 61% women

Adults with chronic low back pain (>12 weeks); trials from Turkey, Spain, USA, Brazil, India, South Korea, Portugal, and Australia (2004–2024)

Full research — for clinicians and curious readers

Study Summary

This systematic review and meta-analysis pooled 15 randomized controlled trials (810 patients with chronic low back pain) to assess whether pain neuroscience education (PNE) — an approach that helps patients reconceptualize how pain works — reduces pain, disability, kinesiophobia (fear of movement), and catastrophizing. PNE, usually combined with exercise or other physiotherapy, was associated with reductions in pain, disability, and kinesiophobia at the end of treatment and at 1 and 3 months of follow-up, and in catastrophizing at the end of treatment and 1 month. The authors rate the trials as good methodological quality on average (PEDro 6.8 ± 1.1) but caution that the small number and size of trials, heterogeneous protocols, and signs of publication bias in some analyses mean results should be interpreted carefully. They note longer-term (6–12 month) effects could not be assessed.

72/100
Evidence StrengthStrong
Study Quality
Sample Size
Replication

Key Findings

FindingDetailImpact
PNE was associated with reduced pain intensity at all three time pointsPooled SMD = −0.65 (95% CI −1.1 to −0.2; p = 0.005) at end of intervention (k = 13); SMD = −1.05 (95% CI −1.56 to −0.53; p < 0.001) at 1 month; SMD = −1 (95% CI −1.5 to −0.5; p < 0.001) at 3 months. Pain was measured with NPRS, VAS, and McGill Pain Questionnaire.High
PNE was associated with reduced disability through 3 monthsSMD = −0.6 (95% CI −1.11 to −0.15; p = 0.009) at end of intervention (k = 10); SMD = −0.78 (95% CI −1.27 to −0.29; p = 0.002) at 1 month; SMD = −0.84 (95% CI −1.42 to −0.26; p = 0.004) at 3 months. Measured with the Roland Morris Disability Questionnaire and Oswestry Disability Index.High
PNE was associated with large reductions in kinesiophobia (fear of movement)SMD = −1.12 (95% CI −1.8 to −0.5; p < 0.001) at end of intervention (k = 6); SMD = −1.51 (95% CI −2.1 to −0.97; p < 0.001) at 1 month; SMD = −1.57 (95% CI −2.47 to −0.66; p = 0.001) at 3 months. Measured with the Tampa Scale of Kinesiophobia.High
PNE was associated with reduced pain catastrophizing at the end of intervention and 1 monthSMD = −0.9 (95% CI −1.61 to −0.17; p = 0.016) at end of intervention (k = 5) and SMD = −1.36 (95% CI −2.34 to −0.37; p = 0.007) at 1 month (k = 3), measured with the Pain Catastrophizing Scale. No data were available to assess catastrophizing at 3 months.Medium
Trials were of good average methodological quality but had recurring biasesMean PEDro score was 6.8 ± 1.1; 13 of 15 RCTs (87%) were rated good and 2 (13%) moderate. Selection bias (5 RCTs), performance bias (nearly all RCTs, since participants/therapists could not be blinded), and detection bias (6 RCTs) were the main limitations.Medium
Publication bias was suggested in some analyses and partly attenuated the effectsTrim-and-fill adjustment for kinesiophobia at end of intervention reduced the effect by 84% (adjusted SMD = −0.70) and for disability at 3 months by 90% (adjusted SMD = −0.44); a smaller 35% adjustment was noted for post-intervention pain. No publication bias was found for catastrophizing.Medium
Study Methodology
Study Design
Systematic review with meta-analysis of randomized controlled trials, conducted per PRISMA 2020 and the Cochrane Handbook; prospectively registered in PROSPERO (CRD420251167278). Pooled effects estimated as Cohen's standardized mean difference (SMD) with 95% CI in a random-effects model; heterogeneity assessed with I² and Q; publication bias assessed with funnel plots, Egger test, and trim-and-fill; leave-one-out sensitivity analysis performed.
Sample Size
15 RCTs; 810 patients (407 PNE/experimental, 403 control)
Duration
Outcomes assessed at three time points: end of intervention, and 1 and 3 months after the intervention; literature search ran from inception to June 2025
Population
Adults with chronic low back pain (>12 weeks); mean age 43.7 ± 5.2 years, approximately 61% women. Trials conducted in Turkey, Spain, USA, Brazil, India, South Korea, Portugal, and Australia between 2004 and 2024.
Outcome Measures
Pain intensity (NPRS, VAS, McGill Pain Questionnaire) · Disability (Roland Morris Disability Questionnaire, Oswestry Disability Index) · Kinesiophobia (Tampa Scale of Kinesiophobia) · Catastrophizing (Pain Catastrophizing Scale) · Methodological quality / risk of bias (PEDro scale)

Strengths

  • Prospectively registered protocol (PROSPERO) and conducted following PRISMA 2020 and the Cochrane Handbook
  • Largest and most up-to-date of the reviews on this topic to date, with 15 RCTs and 810 patients
  • Separated short-term outcomes into distinct time points (end of intervention, 1 month, 3 months) rather than collapsing them
  • Most pooled analyses showed low or null statistical heterogeneity (I² often 0%)
  • Formally assessed publication bias (Egger test, trim-and-fill) and ran leave-one-out sensitivity analyses
  • Excluded studies where other treatments could overshadow the effect of PNE

Limitations

  • Low number of RCTs in several analyses and overall small total sample size, limiting generalizability and precision
  • Chinese and Japanese databases were not searched
  • Selection, performance, and detection biases were present in the included trials and could over- or under-estimate the true effect
  • Publication bias was suggested in some analyses; trim-and-fill substantially lowered effect sizes for kinesiophobia (post-intervention) and disability (3 months)
  • Heterogeneity in PNE protocols and comparators across the included studies makes findings harder to standardize
  • Effects at 6 or 12 months could not be assessed because the included RCTs lacked that data

Key Takeaways for Patients

What This Means for You

  1. Pain neuroscience education (PNE) teaches you how pain works in the nervous system, using metaphors and stories, to help you re-think and worry less about your pain.

  2. In this review of 15 studies, adding PNE to exercise or physiotherapy was linked to less pain, less disability, less fear of movement, and less catastrophizing in people with long-term low back pain.

  3. Benefits for pain, disability, and fear of movement appeared to last at least up to 3 months after treatment ended.

  4. PNE is usually a complement to active treatment like exercise, not a replacement — the studies most often combined the two.

  5. The researchers caution that the trials were small and varied, so results should be viewed as encouraging rather than definitive, and longer-term (6–12 month) effects are still unknown.

Read the Full Paper

Access the complete peer-reviewed study from Medical Sciences (Basel)

View Full Study

Related Research

●●●●● LandmarkSystematic Review

Effectiveness of Percutaneous Needle Electrolysis (PNE) and Intramuscular Electrical Stimulation (IMES) in the Management of Myofascial Pain Syndrome and Tendinopathies: A Systematic Review

Trybulski et al.·Journal of Clinical Medicine·2026

This systematic review found that PNE and IMES may improve pain and function in myofascial pain syndrome and tendinopathies, but evidence quality was limited by high risk of bias. Both techniques appear safe with only minor, self-limiting adverse events.

Systematic Reviews & Meta-analysesRead →
●●●●● LandmarkMeta-analysis

Efficacy of cognitive behavioral therapy for musculoskeletal pain: a systematic review and meta-analysis

Xianjun Liu et al.·Frontiers in Psychology·2026

A meta-analysis of 14 RCTs found that CBT-based interventions produce small-to-moderate reductions in pain intensity and the largest, most consistent reductions in pain catastrophizing for chronic musculoskeletal pain.

Central SensitizationRead →
●●●●● LandmarkSystematic Review

Dry Needling in Sports and Sport Recovery: A Systematic Review with an Evidence Gap Map

Kużdżał et al.·Sports Medicine·2025

This systematic review of 24 studies found dry needling effectively reduces pain in injured athletes but shows mixed results for performance enhancement in healthy athletes. Significant research gaps exist for elite athletes and long-term effects.

Systematic Reviews & Meta-analysesRead →
●●●●● LandmarkSystematic Review

Pain science education and exercise interventions for people with knee or hip osteoarthritis: a systematic review, content and meta-analysis

Anna Louise Hurley-Wallace et al.·BMC Musculoskeletal Disorders·2025

A systematic review and component network meta-analysis finding that pain science education had little-to-no effect on pain or function in knee/hip osteoarthritis but improved catastrophizing, kinesiophobia, and self-efficacy, especially when paired with exercise.

Central SensitizationRead →